Results 11 to 20 of about 17,989 (193)
ANCA associated vasculitis [PDF]
BMJ, 2020 ### What you need to know Nicola, 44, goes to her general practitioner with a one month history of fatigue and night sweats. Physical examination is unremarkable. The duration of her symptoms prompts her GP to consider systemic inflammatory disease. Urinalysis is positive for blood and protein, and blood tests show new renal impairment (serum creatine
Hunter, Robert W +4 more
+12 more sources
ANCA-associated vasculitis [PDF]
Clinical Medicine, 2017 The vasculitides are a heterogeneous group of conditions typified by their ability to cause vessel inflammation with or without necrosis. They present with a wide variety of signs and symptoms and, if left untreated, carry a significant burden of mortality and morbidity.
Yates, Max, Watts, Richard
openaire +4 more sources
ANCA-Associated Vasculitis: An Update [PDF]
Journal of Clinical Medicine, 2021 Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) represents a group of small vessel vasculitides characterized by granulomatous and neutrophilic tissue inflammation, often associated with the production of antibodies that target neutrophil antigens.
Almaani, Salem +4 more
openaire +4 more sources
The Diagnostic and Clinical Utility of Autoantibodies in Systemic Vasculitis
Antibodies, 2019 Considerable progress has been made in understanding the role of autoantibodies in systemic vasculitides (SV), and consequently testing for anti-neutrophil cytoplasmic antibodies (ANCA), anti-glomerular basement membrane antibodies (anti-GBM), and anti ...
Elena Csernok
doaj +1 more source
Checkpoint inhibitor-related renal vasculitis and use of rituximab
Journal for ImmunoTherapy of Cancer, 2020 The percentage of patients with cancer eligible for checkpoint inhibitor (CPI) therapy has increased rapidly over the past few years and approaches 45%.
Noha Abdel-Wahab +6 more
doaj +1 more source
ANCA-associated renal vasculitis [PDF]
Kidney International, 2002 To the Editor: The Nephrology Forum discussed by Professor Savage reminded us of two items about ANCA-associated renal vasculitis (AARV): (1) the complex pathogenesis, where ANCA are much but not enough; and (2) the role of cytokines1.
Campo A, Grill A, STRATTA, Piero
openaire +2 more sources
ANCA Associated Vasculitis Treated with Ultra-low Dose Rituximab: A Case Report
Xiehe Yixue Zazhi, 2023 We reported a case of ANCA-associated vasculitis with pulmonary and renal involvement that was effectively treated with glucocorticoids, cyclophosphamide, and plasma exchange therapy.
WU Haiting, LI Hang
doaj +1 more source
Immunopathogenesis of ANCA-Associated Vasculitis [PDF]
International Journal of Molecular Sciences, 2020 Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis is an autoimmune disorder which affects small- and, to a lesser degree, medium-sized vessels. ANCA-associated vasculitis encompasses three disease phenotypes: granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with polyangiitis (EGPA).
Andreas Kronbichler +32 more
openaire +5 more sources
Journal of the Formosan Medical Association, 2019 Background/Purpose: A reliable noninvasive prognostic factor of ANCA-associated vasculitis (AAV) is still lacking, but little research has focused on the value of MPO-ANCA titers in patients with active vasculitis.
Chieh-Li Yen +8 more
doaj +1 more source
Zaporožskij Medicinskij Žurnal, 2020 The aim of the study – to determine the diagnostic value of serum levels of endothelin-1, alpha-actin-2 and elastin in patients with primary systemic vasculitis. Materials and methods.
L. B. Petelytska, O. B. Yaremenko
doaj +1 more source